Antimicrobial preservatives induce aggregation of interferon alpha-2a: the order in which preservatives induce protein aggregation is independent of the protein.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International journal of pharmaceutics

• Publication date

  2014-09-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2014.06.044PMID 24974985PMCID PMC4268133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a.

  2014cited by this paper
• Effect of antimicrobial preservatives on partial protein unfolding and aggregation.

  2013cited by this paper
• Orthogonal High-Throughput Thermal Scanning Method for Rank Ordering Protein Formulations

  2013cited by this paper
• High-Throughput Biophysical Analysis of Protein Therapeutics to Examine Interrelationships Between Aggregate Formation and Conformational Stability

  2013cited by this paper
• Handbook of Pharmaceutical Excipients

  2012cited by this paper
• Predicting accelerated aggregation rates for monoclonal antibody formulations, and challenges for low-temperature predictions.

  2011cited by this paper
• Mechanisms of m-cresol-induced protein aggregation studied using a model protein cytochrome c.

  2011cited by this paper
• Effect of benzyl alcohol on recombinant human interleukin-1 receptor antagonist structure and hydrogen-deuterium exchange.

  2011cited by this paper
• What is the optimum concentration of m-cresol in antivenoms?

  2011cited by this paper
• Aggregates in monoclonal antibody manufacturing processes

  2011cited by this paper
• Role of partial protein unfolding in alcohol‐induced protein aggregation

  2010cited by this paper
• Immunological mechanism underlying the immune response to recombinant human protein therapeutics.

  2010cited by this paper
• Immunogenicity of aggregates of recombinant human growth hormone in mouse models.

  2009cited by this paper
• Antimicrobial preservative use in parenteral products: past and present.

  2007cited by this paper
• Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.

  2006cited by this paper
• Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor.

  2006cited by this paper
• Temperature dependence of benzyl alcohol- and 8-anilinonaphthalene-1-sulfonate-induced aggregation of recombinant human interleukin-1 receptor antagonist.

  2006cited by this paper
• Effects of protein aggregates: An immunologic perspective

  2006cited by this paper
• Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations.

  2005cited by this paper
• Benzyl alcohol-induced destabilization of interferon-gamma: a study by hydrogen-deuterium isotope exchange.

  2004cited by this paper
• Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution.

  2004cited by this paper
• Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques

  2003cited by this paper
• Kinetics of Protein Aggregation. Quantitative Estimation of the Chaperone-Like Activity in Test-Systems Based on Suppression of Protein Aggregation

  2002cited by this paper
• Cancer immunotherapy: The interferon-α experience

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Cancer immunotherapy: the interferon-alpha experience.

  2002cited by this paper
• Formulation development of protein dosage forms.

  2002cited by this paper
• Development of the antimicrobial effectiveness test as USP chapter <51>.

  2002cited by this paper
• Interaction of insulin with Burkholderia pseudomallei may be caused by a preservative

  2000cited by this paper
• Interleukin-1 Receptor (IL-1R) Liquid Formulation Development Using Differential Scanning Calorimetry

  1998cited by this paper
• Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice

  1997cited by this paper
• Interferon immunogenicity: technical evaluation of interferon-alpha 2a.

  1997cited by this paper
• Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.

  1997cited by this paper
• Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses.

  1997cited by this paper
• Development and Use of Enzyme-Linked Immunosorbent Assays (ELISA) for the Detection of Protein Aggregates in Interferon-Alpha (IFN-α) Formulations

  1997cited by this paper
• Clinical investigation of the immunogenicity of interferon-alpha 2a.

  1997cited by this paper
• Clinical investigation of the immunogenicity of interferon-alpha 2a.

  1997cited by this paper
• Aggregation of recombinant human growth hormone induced by phenolic compounds

  1996cited by this paper
• A turbidimetric method to determine visual appearance of protein solutions.

  1994cited by this paper
• Stability of rhbFGF as determined by UV spectroscopic measurements of turbidity.

  1994cited by this paper
• Nomenclature of the human interferon genes.

  1994cited by this paper
• Techniques for Assessing the Effects of Pharmaceutical Excipients on the Aggregation of Porcine Growth Hormone

  1993cited by this paper
• The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation.

  1993cited by this paper
• Nomenclature of human interferon genes.

  1993cited by this paper
• Antibacterial activity of phenolic compounds and aromatic alcohols.

  1990cited by this paper
• Persistent Cutaneous Insulin Allergy Resulting From High-Molecular-Weight Insulin Aggregates

  1990cited by this paper
• Unfolding free energy changes determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants.

  1988cited by this paper
• Differential expression of human interferon genes.

  1984cited by this paper
• Binding of alcohols to the peptide CO‐group of poly‐L‐proline in the I and II conformation. I. Demonstration of the binding by infrared spectroscopy and optical rotatory dispersion

  1969cited by this paper

• Molecular Mechanisms of Liraglutide Aggregation Induced by Dual Air-Water and Silicone-Oil-Water Interfacial Stress.

  2026cites this paper
• Excipient effect on phenol-induced precipitation of human growth hormone and bovine serum albumin.

  2025cites this paper
• Characterization of Peptide-Preservative Interaction by AlphaFold, Molecular Dynamics Simulation, and NMR Spectroscopy.

  2025cites this paper
• Excipients in biological medicinal products: Functional classification, stability issues, and analytical quantitation approaches

  2025cites this paper
• Study on the evaluation method of cigarette astringency in the simulated oral environment.

  2024cites this paper
• Interaction of preservatives with contact materials during filling and storage of parenteral liquid formulations.

  2024cites this paper
• Development and Validation of a Headspace GC-MS Method for Simultaneous Quantification of Antimicrobial Preservatives in Biopharmaceutical Peptide Formulations.

  2024cites this paper
• Pharmaceutical proteins at the interfaces and the role of albumin

  2024cites this paper
• A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations

  2023cites this paper
• Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview

  2023influential citation
• Antimicrobial adhesive films by plasma-enabled polymerisation of m-cresol

  2022cites this paper
• Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I- Screening of Preservative Combinations.

  2022cites this paper
• Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics.

  2022cites this paper
• Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development.

  2022cites this paper
• Methylparaben as a preservative in the development of a multi-dose HPV-2 vaccine

  2022cites this paper
• High-Throughput Screening for Colloidal Stability of Peptide Formulations Using Dynamic and Static Light Scattering.

  2021cites this paper
• Calorimetric Investigation of the Relaxation Phenomena in Amorphous Lyophilized Solids

  2021cites this paper
• Insulin, not the preservative m-cresol, instigates loss of infusion site patency over extended durations of CSII in diabetic swine.

  2020cites this paper
• Antimicrobial excipient-induced reversible association of therapeutic peptides in parenteral formulations.

  2020cites this paper
• Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens

  2020cites this paper
• Redesigning food protein formulations with empirical phase diagrams: A case study on glycerol-poor and glycerol-free formulations.

  2019cites this paper
• Peptide Optimization at the Drug Discovery-Development Interface: Tailoring of Physicochemical Properties Toward Specific Formulation Requirements.

  2019cites this paper
• Science and Art of Protein Formulation Development.

  2019cites this paper
• Computational methods for long-term protein phase behavior analysis

  2019cites this paper
• Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.

  2018cites this paper
• Stabilization of solution formulation with protein-cosolvent interaction

  2018cites this paper
• Porous reduced graphene oxide modified electrodes for the analysis of protein aggregation. Part 2: Application to the analysis of calcitonin containing pharmaceutical formulation

  2018cites this paper
• Protein aggregation - Mechanisms, detection, and control.

  2018cites this paper
• Trimethylamine N-oxide (TMAO) is a counteracting solute of benzyl alcohol for multi-dose formulation of immunoglobulin.

  2018cites this paper
• Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.

  2017cites this paper
• Developing the Subcutaneous Drug Delivery Route

  2017cites this paper
• Interactions Between Peptide and Preservatives: Effects on Peptide Self-Interactions and Antimicrobial Efficiency In Aqueous Multi-Dose Formulations

  2015cites this paper
• Molecular evolution and functional characterisation of tunicate xenobiotic receptors

  2015cites this paper